Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FQPJC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,218
Award facts
- Contract value 100% obligated
- $1,218.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The order, valued at $1,218.44 with an ultimate completion date of September 24, 2025, was issued on September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, a $500 million vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through its extensive portfolio of federal contract awards covering branded and generic prescription drugs, biologics, vaccines, and specialty medications including oncology treatments and contraceptive devices. The company's woman-owned small business status and consistent performance on DLA contracts demonstrate its capability to support Department of Defense healthcare logistics requirements. EXPAREL, a local anesthetic commonly used in surgical and pain management applications, represents one of the specialized pharmaceutical products within the company's federal distribution portfolio serving military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FQPJC?
SPE2DB25FQPJC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQPJC worth?
The government has obligated $1,218 on SPE2DB25FQPJC.
Is contract SPE2DB25FQPJC an order under another contract?
Yes. SPE2DB25FQPJC is a delivery order under SPE2DB25D9240, an indefinite delivery contract.
Was contract SPE2DB25FQPJC competed?
The extent of competition for SPE2DB25FQPJC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award